The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases

Even though anti-TNF therapy significantly improves the rates of remission in inflammatory bowel disease (IBD) patients, there is a noticeable subgroup of patients who do not respond to treatment. Dysbiosis emerges as a key factor in IBD pathogenesis. The aim of the present study is to profile chang...

Descripción completa

Detalles Bibliográficos
Autores principales: Dovrolis, Nikolas, Michalopoulos, George, Theodoropoulos, George E., Arvanitidis, Kostantinos, Kolios, George, Sechi, Leonardo A., Eliopoulos, Aristidis G., Gazouli, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143962/
https://www.ncbi.nlm.nih.gov/pubmed/32244928
http://dx.doi.org/10.3390/microorganisms8030438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143962/
https://www.ncbi.nlm.nih.gov/pubmed/32244928
http://dx.doi.org/10.3390/microorganisms8030438

Ejemplares similares